Pacibekitug

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NamePacibekitug
Drug Alias NamePF-4236921PF-04236921TOUR006TOUR-006
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-6 inhibitors
TargetsInterleukin-6
Therapy Area/IndicationsLupus Erythematosus, SystemicCardiovascular DiseasesRenal Insufficiency, Chronic +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[31
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesTourmaline Bio Inc
Inactive CompaniesPfizer Inc
Active IndicationsCardiovascular DiseasesRenal Insufficiency, ChronicGraves Ophthalmopathy
Inactive IndicationsLupus Erythematosus, SystemicCrohn DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A